Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
   Pooled it
2. Unlocking mRNA-driven CRISPR-Cas9 gene therapy via optimizing mRNA and the delivery vectors.Molecular therapy. Nucleic acids · 2025
   Review
3. IRES-Mediated Translation: Expanding the Toolkits of RNA Therapy.International journal of molecular sciences · 2025
   Review
4. Targeted lipid nanoparticles to prevent trans-placental passage in the ex vivo human placental cotyledon perfusion model.Drug delivery and translational research · 2025
   Article
5. Polymeric nanocarriers for therapeutic gene delivery.Asian journal of pharmaceutical sciences · 2025
   Review
6. Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats.Frontiers in immunology · 2025
   Article
7. Advances in Engineering Circular RNA Vaccines.Pathogens (Basel, Switzerland) · 2024
   Review
8. The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in Macao.Chinese medicine · 2024
   Article
9. Circular RNA vaccine in disease prevention and treatment.Signal transduction and targeted therapy · 2023
   Review
10. Association between SARS-CoV-2 Symptoms, Ct Values, and Serological Response in Vaccinated and Unvaccinated Healthcare Personnel.The journal of applied laboratory medicine · 2023
    Article
11. Status of and perspectives on COVID-19 vaccination after lifting of the dynamic zero-COVID policy in China.Global health & medicine · 2023
    Article
12. Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study.RMD open · 2023
    Article
13. CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2.PloS one · 2023
    Article
14. Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-β-coronavirus vaccines.Journal of medical virology · 2023
    Review
15. Immunization with a novel mRNA vaccine, TGGT1_216200 mRNA-LNP, prolongs survival time in BALB/c mice against acute toxoplasmosis.Frontiers in immunology · 2023
    Article
16. Development of facial palsy following COVID-19 vaccination: A systematic review.Annals of medicine and surgery (2012) · 2022
    Review
17. Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces, China.Virologica Sinica · 2022
    Article
18. Anti-Inflammatory Therapy for Temporomandibular Joint Osteoarthritis Using mRNA Medicine Encoding Interleukin-1 Receptor Antagonist.Pharmaceutics · 2022
    Article
19. Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022
    Article
20. Mapping the intersection of nanotechnology and SARS-CoV-2/COVID-19: A bibliometric analysis.Infectious medicine · 2022
    Article

Corrections and comments

• Commented on by
  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.2021
• Comment on
  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as